Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Biaya Penjualan
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 14.05B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Biaya Penjualan
Perubahan
Tanggal
Agilent
USD 845M
7M
2026-03
Align Technology
USD 303.5M
60.47M
2026-03
Bio Techne
USD 103.13M
1.47M
2026-03
Bio-Rad Laboratories
USD 348M
38.4M
2025-12
Bruker
USD 443.6M
84.4M
2026-03
Celltrion
KRW 107.42B
295.44B
2025-12
Charles River Laboratories
USD 716.51M
5.76M
2026-03
Cspc Pharmaceutical
CNY 2.11B
173.58M
2025-12
Danaher
USD 2.36B
512M
2026-03
Dentsply International
USD 453M
65M
2026-03
Deva Holding AS
TRY 991.13M
182.81M
2023-09
Divis Laboratories Ltd
INR 12.39B
1.76B
2026-03
Edwards Lifesciences
USD 362.6M
19.6M
2026-03
Illumina
USD 370M
30M
2026-03
Intuitive Surgical
USD 940.3M
21.6M
2026-03
IQVIA Holdings
USD 3.08B
161M
2026-03
Kangmei Pharma
CNY 841.45M
271.27M
2026-03
Knight Therapeutics
CAD 82.22M
1.03M
2025-12
Laboratorios Farma
EUR 186.09M
11.06M
2023-12
Laboratory Of America
USD 2.6B
4.2M
2026-03
Medical Developments International
AUD 7.09M
4.91M
2025-12
Mesa Laboratories
USD 21.92M
1.78M
2024-09
Mettler Toledo International
USD 410.92M
63.05M
2026-03
Myriad Genetics
USD 63M
1.1M
2025-12
Neuren Pharmaceuticals
AUD 7.45M
6.56M
2025-06
OraSure Technologies
USD 15.43M
113K
2025-12
Organigram Holdings
CAD 43.39M
13.54M
2026-03
Pacific Biosciences Of California
USD 28.9M
10M
2025-12
Pharma Mar
EUR 3.66M
116K
2026-03
Qiagen NV
USD 217.43M
29.65M
2025-12
Quest Diagnostics
USD 1.99B
57M
2026-03
Quidel
USD -79.5M
528.3M
2026-03
Repligen
USD 85.97M
8.11M
2026-03
Revvity
USD 323.46M
26.93M
2026-03
Sartorius
EUR 484.6M
46.6M
2026-03
Sino Biopharmaceutical
CNY 3.08B
589.65M
2025-06
Thermo Fisher Scientific
USD 6.96B
620M
2026-03
Tilray
USD 164.37M
8.41M
2025-09
Waters
USD 725M
350.06M
2026-03
Zealand Pharma A/S
410K
5K
2025-06
Zz Pientze Pharmaceu
CNY 1.58B
245.15M
2026-03
×